Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX4 plus cetuximab in untreated advanced colorectal cancer
2004-004181-32Phase 2Completed
- Sponsor
- Oncology Institute of Bari
- Start
- Jul 2007
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab, oxaliplatin, levoleucovorin and fluorouracil in colorectal cancer (CRC), sponsored by Oncology Institute of Bari. Primary endpoint: Objective response rate. Started Jul 2007; status: completed.
02
Drugs
cetuximaboxaliplatinlevoleucovorinfluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2004-004181-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004181-32.